DANIELLE STROHMEYER: Open Payments
NPI 1275156010 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 54 payments from 19 companies in 2025. Trend: 2023 $2,344 · 2024 $2,634 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $185 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| Janssen Pharmaceuticals, Inc | 4 | $81 |
| ABBVIE INC. | 4 | $80 |
| Lilly USA, LLC | 4 | $65 |
| PFIZER INC. | 3 | $61 |
| Dexcom, Inc. | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
Products named: AIRSUPRA, SPRAVATO, Wegovy, FARXIGA, NURTEC ODT, Dexcom G6 Transmitter, Ozempic, MOUNJARO.
Industry payments across OK — which companies pay providers there.
